Advertisement
The announcement is pursuant to a previously announced election by theCompany's Board of Directors, and is the culmination of a succession plan thatbegan in April 2006 when Mr. Poussot was promoted to President and ViceChairman. In January 2007, he was named President and Chief Operating Officerand was elected to the Company's Board of Directors. He became CEO on January1, 2008.
Advertisement
The Company announced in April that Robert Essner, 60, had decided toretire from the Company effective June 27, 2008. Mr. Essner held the positionof Chairman since January 2003 and served as Wyeth's Chief Executive Officerfrom 2001 to 2007.
Wyeth is one of the world's largest research-driven pharmaceutical andhealth care products companies. It is a leader in the discovery, development,manufacturing and marketing of pharmaceuticals, vaccines, biotechnologyproducts, nutritionals and non-prescription medicines that improve the qualityof life for people worldwide. The Company's major divisions include WyethPharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
SOURCE Wyeth
